Skip to main content
CivicGate

S 9497 NY

Requires insurers to cover the substitution of a brand name prescription drug when the federal food and drug administration has declared that there is a supply issue with a generic drug

NY · session 2025-2026 · Senate · bill

A state bill is a proposed law in a state legislature — separate from the U.S. Congress. Learn more →

Introduced Mar 18, 2026

Latest action (Jun 1, 2026) SUBSTITUTED BY A1428

Summary

This bill would require health insurers to cover the substitution of a brand name prescription drug when the federal Food and Drug Administration has declared a supply shortage for the corresponding generic drug. The measure ensures that patients have access to medication when generics are unavailable due to supply issues.

AI-generated plain-language summary of the bill (from the OpenStates abstract — no full text available yet) — neutral, and may be imperfect.

Official abstract

Requires insurers to cover the substitution of a brand name prescription drug when the federal food and drug administration has declared that there is a supply issue with a generic drug.

Sponsor (1)

Action history (5)

  1. Mar 18, 2026 REFERRED TO INSURANCE · upper
  2. Apr 20, 2026 REPORTED AND COMMITTED TO FINANCE · upper
  3. Jun 1, 2026 COMMITTEE DISCHARGED AND COMMITTED TO RULES · upper
  4. Jun 1, 2026 ORDERED TO THIRD READING CAL.1489 · upper
  5. Jun 1, 2026 SUBSTITUTED BY A1428 · upper

Full text

The full text hasn’t been imported yet. CivicGate fetches it from the state legislature’s published version documents — check now.

Comments

Comments

Loading comments…

Data from OpenStates. View on OpenStates →